Works matching DE "GLUCAGON-like peptide 1"
Results: 2974
Glucagon-Like Peptide 1 Receptor (Glp1r) Deficiency Does Not Appreciably Alter Airway Inflammation or Gut-Lung Microbiome Axis in a Mouse Model of Obese Allergic Airways Disease and Bariatric Surgery.
- Published in:
- Journal of Asthma & Allergy, 2025, v. 18, p. 285, doi. 10.2147/JAA.S478329
- By:
- Publication type:
- Article
Sweet Solutions: Unlocking the Diabetes-Dementia Connection for Better Outcomes.
- Published in:
- Journal of Insurance Medicine, 2025, v. 52, n. 1, p. 14, doi. 10.17849/insm-52-1-14-20.1
- By:
- Publication type:
- Article
Integration of Glucagon-Like Peptide 1 Receptor Actions Through the Central Amygdala.
- Published in:
- Endocrinology, 2025, v. 166, n. 3, p. 1, doi. 10.1210/endocr/bqaf019
- By:
- Publication type:
- Article
Association between GLP-1 RAs and DPP-4 inhibitors with biliary disorders: pharmacovigilance analysis.
- Published in:
- Frontiers in Pharmacology, 2025, p. 1, doi. 10.3389/fphar.2025.1509561
- By:
- Publication type:
- Article
Changes in food preferences after oral semaglutide administration in Japanese patients with type 2 diabetes: KAMOGAWA-DM cohort.
- Published in:
- Diabetes & Vascular Disease Research, 2025, v. 22, n. 1, p. 1, doi. 10.1177/14791641251318309
- By:
- Publication type:
- Article
Enhancing Tetrahydrocannabinol's Therapeutic Efficacy in Inflammatory Bowel Disease: The Roles of Cannabidiol and the Cannabinoid 1 Receptor Allosteric Modulator ZCZ011.
- Published in:
- Pharmaceuticals (14248247), 2025, v. 18, n. 2, p. 148, doi. 10.3390/ph18020148
- By:
- Publication type:
- Article
Sodium–Glucose Cotransporter 2 Inhibitors and Lower-Extremity Amputation: Is the Guilty Verdict Valid?
- Published in:
- Diabetes Care, 2025, v. 48, n. 3, p. 338, doi. 10.2337/dci24-0101
- By:
- Publication type:
- Article
Response to Comment on Foss-Freitas et al. Efficacy and Safety of Glucagon-Like Peptide 1 Agonists in a Retrospective Study of Patients With Familial Partial Lipodystrophy. Diabetes Care 2024;47:653–659.
- Published in:
- 2025
- By:
- Publication type:
- Letter
One Size Does Not Fit All: Understanding Microdosing Semaglutide for Diabetes in Multidose Pens.
- Published in:
- 2025
- By:
- Publication type:
- Letter
Exploring Kidney Oxygenation Responses to Dapagliflozin, Exenatide, and Their Combination in Patients With Type 2 Diabetes and Chronic Kidney Disease: Observations From a Prespecified Pilot Study of a Randomized Crossover Trial.
- Published in:
- 2025
- By:
- Publication type:
- Letter
Glucagon-Like Peptide 1 Receptor Agonists and Sodium–Glucose Cotransporter 2 Inhibitors and the Prevention of Cirrhosis Among Patients With Type 2 Diabetes.
- Published in:
- Diabetes Care, 2025, v. 48, n. 3, p. 444, doi. 10.2337/dc24-1903
- By:
- Publication type:
- Article
Prescribing Trends of Glucose-Lowering Medications Near End of Life Among Adults With Type 2 Diabetes: A Cohort Study.
- Published in:
- Diabetes Care, 2025, v. 48, n. 3, p. 455, doi. 10.2337/dc24-1795
- By:
- Publication type:
- Article
Comment on Foss-Freitas et al. Efficacy and Safety of Glucagon-Like Peptide 1 Agonists in a Retrospective Study of Patients With Familial Partial Lipodystrophy. Diabetes Care 2024;47:653–659.
- Published in:
- 2025
- By:
- Publication type:
- Letter
Comparative Efficacy of Glucagon-Like Peptide 1 Receptor Agonists for Cardiovascular Outcomes in Asian Versus White Populations: Systematic Review and Meta-analysis of Randomized Trials of Populations With or Without Type 2 Diabetes and/or Overweight or Obesity
- Published in:
- Diabetes Care, 2025, v. 48, n. 3, p. 489, doi. 10.2337/dc24-1533
- By:
- Publication type:
- Article
Capsaicin (But Not Other Vanillins) Enhances Estrogen Binding to Its Receptor: Implications for Power Sports and Cancers.
- Published in:
- Life (2075-1729), 2025, v. 15, n. 2, p. 208, doi. 10.3390/life15020208
- By:
- Publication type:
- Article
The Incretin Effect of Yerba Maté (Ilex paraguariensis) Is Partially Dependent on Gut-Mediated Metabolism of Ferulic Acid.
- Published in:
- Nutrients, 2025, v. 17, n. 4, p. 625, doi. 10.3390/nu17040625
- By:
- Publication type:
- Article
Postprandial Adiponectin Levels Are Associated with Improvements in Postprandial Triglycerides After Roux-en-Y Gastric Bypass in Type 2 Diabetic Patients.
- Published in:
- Metabolic Syndrome & Related Disorders, 2013, v. 11, n. 5, p. 343, doi. 10.1089/met.2012.0042
- By:
- Publication type:
- Article
The Vagotomy Alleviates the Anorectic Effect of an Excess Amount of Dietary Leucine on Rats Fed a Low-Protein Diet.
- Published in:
- Bioscience, Biotechnology & Biochemistry, 2013, v. 77, n. 7, p. 1593, doi. 10.1271/bbb.130150
- By:
- Publication type:
- Article
One-Step Purification of a Fusion Protein of Glucagon-Like Peptide-1 and Human Serum Albumin Expressed in Pichia pastoris by an Immunomagnetic Separation Technique.
- Published in:
- Bioscience, Biotechnology & Biochemistry, 2007, v. 71, n. 11, p. 2655, doi. 10.1271/bbb.70190
- By:
- Publication type:
- Article
High-Level Expression of Fusion Protein Containing 10 Tandem Repeated GLP-1 Analogs in Yeast Pichia pastoris and Its Biological Activity in a Diabetic Rat Model.
- Published in:
- Bioscience, Biotechnology & Biochemistry, 2007, v. 71, n. 6, p. 1462, doi. 10.1271/bbb.60694
- By:
- Publication type:
- Article
The Design of a GLP‐1/PYY Dual Acting Agonist.
- Published in:
- Angewandte Chemie, 2021, v. 133, n. 15, p. 8349, doi. 10.1002/ange.202016464
- By:
- Publication type:
- Article
International Accolades for GLP-1 Research: Recognizing Pioneers in Diabetes and Obesity Treatment Across Five Prestigious Awards.
- Published in:
- Cardiovascular Drugs & Therapy, 2025, v. 39, n. 1, p. 9, doi. 10.1007/s10557-024-07630-9
- By:
- Publication type:
- Article
Liraglutide Protects Against Diastolic Dysfunction and Improves Ventricular Protein Translation.
- Published in:
- Cardiovascular Drugs & Therapy, 2024, v. 38, n. 6, p. 1289, doi. 10.1007/s10557-023-07482-9
- By:
- Publication type:
- Article
Dipeptidyl Peptidase-4 Inhibitor Decreases Allograft Vasculopathy Via Regulating the Functions of Endothelial Progenitor Cells in Normoglycemic Rats.
- Published in:
- Cardiovascular Drugs & Therapy, 2021, v. 35, n. 6, p. 1111, doi. 10.1007/s10557-020-07013-w
- By:
- Publication type:
- Article
Predictors of efficacy of Sodium‐GLucose Transporter‐2 inhibitors and Glucagon‐Like Peptide 1 receptor agonists: A retrospective cohort study.
- Published in:
- Diabetes/Metabolism Research & Reviews, 2024, v. 40, n. 2, p. 1, doi. 10.1002/dmrr.3727
- By:
- Publication type:
- Article
The new dual gastric inhibitory peptide/glucagon‐like peptide 1 agonist tirzepatide in type 2 diabetes: Is the future bright?
- Published in:
- Diabetes/Metabolism Research & Reviews, 2021, v. 37, n. 8, p. 1, doi. 10.1002/dmrr.3503
- By:
- Publication type:
- Article
Switching from insulin to dulaglutide therapy in patients with type 2 diabetes: A real-world data study.
- Published in:
- 2021
- By:
- Publication type:
- journal article
The Mediterranean diet increases glucagon‐like peptide 1 and oxyntomodulin compared with a vegetarian diet in patients with type 2 diabetes: A randomized controlled cross‐over trial.
- Published in:
- Diabetes/Metabolism Research & Reviews, 2021, v. 37, n. 6, p. 1, doi. 10.1002/dmrr.3406
- By:
- Publication type:
- Article
Glucose‐lowering pharmacotherapies in Chinese adults with type 2 diabetes and cardiovascular disease or chronic kidney disease. An expert consensus reported by the Chinese Diabetes Society and the Chinese Society of Endocrinology.
- Published in:
- Diabetes/Metabolism Research & Reviews, 2021, v. 37, n. 4, p. 1, doi. 10.1002/dmrr.3416
- By:
- Publication type:
- Article
The use of GLP-1 receptor agonists in hospitalised patients: An untapped potential.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Glucagon-like peptide-1 receptor agonists in type 2 diabetes treatment: are they all the same?
- Published in:
- 2019
- By:
- Publication type:
- journal article
Activation of microglial GLP-1R in the trigeminal nucleus caudalis suppresses central sensitization of chronic migraine after recurrent nitroglycerin stimulation.
- Published in:
- Journal of Headache & Pain, 2021, v. 22, n. 1, p. 1, doi. 10.1186/s10194-021-01302-x
- By:
- Publication type:
- Article
Functional evaluations comparing Billroth I with a large remnant stomach and Roux en Y with a small remnant stomach following laparoscopic distal gastrectomy for gastric cancer: An investigation including laparoscopic total gastrectomy.
- Published in:
- Surgery Today, 2023, v. 53, n. 2, p. 232, doi. 10.1007/s00595-022-02557-w
- By:
- Publication type:
- Article
Successful Pregnancy after Improving Insulin Resistance with the Glucagon-Like Peptide-1 Analogue in a Woman with Polycystic Ovary Syndrome: A Case Report and Review of the Literature.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Split Ssp DnaB mini-intein-mediated production of recombinant human glucagon-like peptide-1/7-36.
- Published in:
- Biotechnology & Applied Biochemistry, 2015, v. 62, n. 3, p. 309, doi. 10.1002/bab.1274
- By:
- Publication type:
- Article
CIRURGIA METABÓLICA COMO TRATAMENTO CIRÚRGICO DO DIABETES TIPO II.
- Published in:
- Revista Foco (Interdisciplinary Studies Journal), 2023, v. 16, n. 9, p. 1, doi. 10.54751/revistafoco.v16n9-098
- By:
- Publication type:
- Article
In silico ADME and target prediction studies of Alogliptin as drug molecule.
- Published in:
- Drug Metabolism Reviews, 2025, v. 57, n. 1, p. 1, doi. 10.1080/03602532.2024.2439102
- By:
- Publication type:
- Article
156. IN VITRO EVALUATION OF HUMAN DRUG METABOLIZING ENZYMES USING AUTOMATED, HIGHLY SENSITIVE, GLP COMPLIANT METHODS.
- Published in:
- 2002
- Publication type:
- Abstract
'No Strong Evidence' to Support Discontinuation of GLP-1RAs Prior to Upper Endoscopy.
- Published in:
- Healio Gastroenterology, 2024, v. 10, n. 10, p. 17
- By:
- Publication type:
- Article
Manage Lifestyle Early and Aggressively to Prevent, Instead of Treat, Fatty Liver.
- Published in:
- Healio Gastroenterology, 2024, v. 10, n. 7, p. 18
- By:
- Publication type:
- Article
'Unequivocally Yes': MASH Therapies Still Needed Despite Boom in GLP-1 Use in Liver Disease.
- Published in:
- Healio Gastroenterology, 2024, v. 10, n. 7, p. 17
- By:
- Publication type:
- Article
'Highly Plausible' GLP-1s Can Improve Health-Related QoL, Economic Burden of MASH.
- Published in:
- Healio Gastroenterology, 2024, v. 10, n. 7, p. 7
- By:
- Publication type:
- Article
Effect of feeding fat or intrajugular infusion of glucagon-like peptide-1 and cholecystokinin on dry matter intake, digestibility, and digesta rate of passage in growing wethers.
- Published in:
- Journal of Animal Science, 2011, v. 89, n. 1, p. 168, doi. 10.2527/jas.2010-2976
- By:
- Publication type:
- Article
Effect of feed restriction and supplemental dietary fat on gut peptide and hypothalamic neuropeptide messenger ribonucleic acid concentrations in growing wethers.
- Published in:
- Journal of Animal Science, 2010, v. 88, n. 2, p. 737, doi. 10.2527/jas.2009-2316
- By:
- Publication type:
- Article
Gut peptide concentrations and dry matter intake in lactating dairy cows fed rumen-inert fats differing in degree of saturation.
- Published in:
- Journal of Animal Science, 2006, v. 84, p. 196
- By:
- Publication type:
- Article
Intestinal Nutrient-Gene Interaction: The effect of Feed Deprivation and Refeeding On...
- Published in:
- Journal of Animal Science, 1998, v. 76, n. 12, p. 3104, doi. 10.2527/1998.76123104x
- By:
- Publication type:
- Article
Effect of 6 weeks of very low-volume high-intensity interval training on oral glucose-stimulated incretin hormone response.
- Published in:
- European Journal of Sport Science, 2022, v. 22, n. 3, p. 381, doi. 10.1080/17461391.2021.1877830
- By:
- Publication type:
- Article
Impact of metformin timing on glucose and GLP-1 response.
- Published in:
- Diabetes & Primary Care, 2024, v. 26, n. 4, p. 143
- By:
- Publication type:
- Article
HOW TO USE GLP-1 RECEPTOR AGONIST THERAPY SAFELY AND EFFECTIVELY.
- Published in:
- Diabetes & Primary Care, 2020, v. 22, n. 6, p. 135
- By:
- Publication type:
- Article
More patients achieved composite reductions of ≥1% HbA<sub>1c</sub>, ≥5% body weight and ≥5 mmHg systolic blood pressure with semaglutide versus comparators (SUSTAIN 1-5, 7).
- Published in:
- Diabetes & Primary Care, 2019, v. 21, n. 5, p. 184
- By:
- Publication type:
- Article